Stronger technical forecast for Moderna stock price after Friday trading.
(Updated on Sep 30, 2022)
Sell candidate since 2022-09-21 Loss -5.97% PDF
The Moderna stock price gained 0.15% on the last trading day (Friday, 30th Sep 2022), rising from $118.07 to $118.25. During the last trading day the stock fluctuated 3.81% from a day low at $118.08 to a day high of $122.58. The price has fallen in 7 of the last 10 days and is down by -14.15% for this period. Volume fell on the last day by -901 thousand shares and in total, 4 million shares were bought and sold for approximately $455.64 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $117.21 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -25.32% during the next 3 months and, with a 90% probability hold a price between $87.53 and $119.33 at the end of this 3-month period.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, September 29, 2022, and so far it has risen 0.15%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Moderna stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $121.19 and $137.84. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.50 between high and low, or 3.81%. For the last week, the stock has had daily average volatility of 4.33%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Moderna Inc. to open at $119.64, and during the day (based on 14 day Average True Range), to move between $111.61 and $124.89, which gives a possible trading interval of +/-$6.64 (+/-5.62%) up or down from last closing price. If Moderna Inc. takes out the full calculated possible swing range there will be an estimated 11.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $118.07 (0.15%) than the resistance at $127.90 (8.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Moderna Inc. stock A Buy?
Moderna holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -3.773Sell Candidate Upgraded
Predicted Opening Price for Moderna Inc. of Monday, October 3, 2022
The predicted opening price is based on yesterday's movements between high, low, and closing price.
|Fair opening price October 3, 2022||Current price|
Remember To Visit Our YouTube Channel
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
About Moderna Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus... MRNA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.